top of page
TB 500 10mg
TB 500 10mg

TB 500 10mg

$70.00Price
Quantity

TB-500

TB-500 is a synthetic 7-amino acid fragment (Ac-LKKTETQ) derived from thymosin beta-4, the principal actin-sequestering protein in mammalian cells. Originally developed for veterinary use in horses, this fragment retains powerful tissue repair and anti-inflammatory properties while being more stable than the full peptide. TB-500 works systemically to regulate cell migration, promote angiogenesis, reduce inflammation, and activate stem cell differentiation for accelerated healing across muscles, tendons, ligaments, and organs. It's banned by WADA for its performance-enhancing effects and is well-researched for athletic recovery and injury healing.

MECHANISM OF ACTION

TB-500 acts as an actin-sequestering protein that regulates the availability of actin monomers in cells. By controlling actin dynamics, it promotes cell migration and tissue remodeling, stimulates angiogenesis (new blood vessel formation) to deliver oxygen and nutrients to damaged tissue, reduces inflammatory cytokines that impede healing, and activates stem cell differentiation to regenerate damaged tissue.

This multi-pathway approach makes it one of the most comprehensive tissue repair compounds — it doesn't just reduce inflammation or stimulate growth, it orchestrates the entire healing process at the cellular level.

POTENTIAL BENEFITS

  • Dramatically accelerated muscle healing and regeneration

  • Faster recovery from tendon and ligament injuries

  • Enhanced angiogenesis and blood flow to damaged tissue

  • Reduced inflammation and pain in injured areas

  • Improved tissue quality and strength post-injury

  • Enhanced athletic recovery and reduced soreness

  • Support for organ tissue repair and cardiac function

  • Neuroprotection and spinal cord support

  • Improved wound healing (topical formulation)

  • Dry eye treatment and corneal repair (topical eye drops)

WHY IT'S BEING RESEARCHED

TB-500 is being researched because it addresses the fundamental bottleneck in tissue repair — the speed and quality of healing.

A 2016 pilot study showed TB-500 pre-treated endothelial progenitor cells improved left ventricular function by over 50% in post-MI cardiac patients. A 2015 study demonstrated TB-500 improved skeletal muscle fiber regeneration in dystrophin-deficient mice, showing potential for muscular dystrophy.

Its multi-pathway mechanism (angiogenesis, inflammation reduction, stem cell activation, cell migration) makes it uniquely effective for injuries that don't respond well to single-target therapies. Topical formulations are being researched for chronic wounds and dry eye disease.

INTERESTING FACTS

  • Derived from thymosin beta-4, one of the most abundant proteins in mammalian cells

  • Only 7 amino acids — one of the smallest active peptide fragments

  • Originally used in veterinary medicine for racehorses; now widely researched in humans

  • Banned by WADA due to its powerful performance-enhancing effects on tissue repair

  • Works systemically — injected subcutaneously or intramuscularly, distributes throughout the body

  • Effects visible within 1–2 weeks: reduced inflammation and improved tissue sensation

  • Maximum benefits typically appear by week 4–8

  • Can be used continuously without mandatory breaks, though 4–6 week breaks between cycles are common

  • Topical formulations (gels, eye drops) provide localized healing without systemic effects

  • Synergizes powerfully with BPC-157 and growth hormone-releasing peptides

  • Molecular weight only 889 Da — extremely small and stable

STACKING

Common research combinations include:

BPC-157 for comprehensive tissue repair synergy

TB-500 promotes angiogenesis and stem cell activation while BPC-157 enhances growth factor signaling and reduces inflammation through different pathways. Both work systemically on healing but through complementary mechanisms. No documented negative interactions; many users report superior results stacking both.

Growth Hormone or CJC-1295/Ipamorelin for accelerated muscle and tissue regeneration

GH increases IGF-1 and protein synthesis while TB-500 optimizes tissue remodeling and angiogenesis. Synergistic for muscle hypertrophy and injury recovery. No known interactions.

IGF-1 LR3 for enhanced muscle growth and tissue quality

IGF-1 drives protein synthesis and myoblast proliferation while TB-500 promotes angiogenesis and stem cell differentiation. Powerful combination for muscle building and injury repair. No documented interactions.

GHK-CU for collagen synthesis and skin/tissue quality

TB-500 promotes tissue remodeling and angiogenesis while GHK-CU stimulates collagen production and wound healing. Synergistic for skin quality, scar reduction, and connective tissue strength.

Thymosin Alpha-1 for immune support during healing

TB-500 accelerates tissue repair while Thymosin Alpha-1 enhances immune function to clear debris and support the healing environment. Complementary mechanisms with no known interactions.

Sermorelin for growth hormone elevation without exogenous GH

TB-500 optimizes tissue remodeling while Sermorelin naturally elevates endogenous GH for anabolic support. Gentler alternative to exogenous GH stacking.

TB-500 is well-tolerated and has no documented serious interactions with other peptides or compounds in research settings.



RESEARCH PURPOSES ONLY

NOT AVAILABLE FOR HUMAN CONSUMPTION

    bottom of page